Published July 2013 | Version v1
Journal article

Pulsed low-dose irradiation of orthotopic glioblastoma multiforme (GBM) in a pre-clinical model: Effects on vascularization and tumor control

Description

Background and purpose: To compare dose-escalated pulsed low-dose radiation therapy (PLRT) and standard radiation therapy (SRT). Methods and materials: Intracranial U87MG GBM tumors were established in nude mice. Animals received whole brain irradiation with daily 2-Gy fractions given continuously (SRT) or in ten 0.2-Gy pulses separated by 3-min intervals (PLRT). Tumor response was evaluated using weekly CT and [18F]-FDG-PET scans. Brain tissue was subjected to immunohistochemistry and cytokine bead array to assess tumor and normal tissue effects. Results: Median survival for untreated animals was 18 (SE ± 0.5) days. A significant difference in median survival was seen between SRT (29 ± 1.8 days) and PLRT (34.2 ± 1.9 days). Compared to SRT, PLRT resulted in a 31% (p < 0.01), 38% (p < 0.01), and 53% (p = 0.01) reduction in normalized tumor volume and a 48% (p < 0.01), 51% (p < 0.01), and 70% (p < 0.01) reduction in tumor growth rate following the administration of 10 Gy, 20 Gy, and 30 Gy, respectively. Compared to untreated tumors, PLRT resulted in similar tumor vascular density, while SRT produced a 40% reduction in tumor vascular density (p = 0.05). Compared to SRT, PLRT was associated with a 28% reduction in degenerating neurons in the surrounding brain parenchyma (p = 0.05). Conclusions: Compared to SRT, PLRT resulted in greater inhibition of tumor growth and improved survival, which may be attributable to preservation of vascular density

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2013.05.022

Additional details

Identifiers

DOI
10.1016/j.radonc.2013.05.022;
PII
S0167-8140(13)00242-9;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
108
Journal Issue
1
Journal Page Range
p. 149-154
ISSN
0167-8140
CODEN
RAONDT

Optional Information

Copyright
Copyright (c) 2013 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.